Source: International Congress 2016 – The nature of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Claudio Schuoler (Zurich, Switzerland), Claudio Schuoler, Thomas Haider, Caroline Leuenberger, Johannes Vogel, Louise Ostergaard, Malcolm Kohler, Max Gassmann, Lars Huber, Matthias Brock. Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice. Eur Respir J 2016; 48: Suppl. 60, 5104

Member's Comments

No comment yet.

Related content which might interest you: Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Inhibition of the miRNA familiy miR-130 restores the expression of CDKN1A (p21) and ameliorates hypoxia-induced pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Role of the TrkA receptor in experimental severe pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Contributions of TRPV4 to altered pulmonary vasoreactivity in mice with pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Siah2 in pulmonary hypertension and right ventricular hypertrophy Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Cystic fibrosis transmembrane conductance regulator and sphingolipids regulate hypoxic pulmonary vasoconstriction Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 LATE-BREAKING ABSTRACT: KCNK3 dysfunction contributes to the development of pulmonary arterial hypertension – Characterization of Kcnk3 deficient rats Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Hypoxia-induced pulmonary artery fibroblast proliferation and migration is prevented by ASK1 inhibition in an in vitro cellular model of pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Temporal hemodynamic and histological changes in a rat model of SUGEN-induced PAH Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015